Moreno-Vedia, Juan
Llop, Dídac
Rodríguez-Calvo, Ricardo
Plana, Núria
Amigó, Núria
Rosales, Roser
Esteban, Yaiza
Girona, Josefa
Masana, Lluís
Ibarretxe, Daiana
Funding for this research was provided by:
Instituto de Salud Carlos III (PI18/00515)
Article History
Received: 3 July 2023
Accepted: 12 August 2023
First Online: 14 September 2023
Declarations
:
: This study was approved by the Ethical and Clinical Investigation Committee of the Pere Virgili Institute for Health Research (IISPV) and fulfilled the principles of the Helsinki Declaration. All the participants included in the study signed a written consent.
: We agree that the data are original and not currently under review elsewhere, and we consent to their publication.
: Núria Amigó is CEO and co-founder of Biosfer Teslab SL. The rest of the authors declare that there were no financial or commercial relations that may be viewed as potential conflicts of interest.